Form 4: BDX Director Sells 863 Shares

Becton Dickinson Director Claire Fraser reported the sale of 863 common shares at $192.30 per share, reducing her direct beneficial ownership.

Summary

• Director Claire Fraser of Becton Dickinson & Co. (BDX) reported a sale of common stock.
• The transaction involved the disposition of 863 shares of BDX common stock.
• The shares were sold at a price of $192.30 per share.
• The reported transaction date is August 8, 2025.
• Following this transaction, Claire Fraser directly owns 23,143 shares of BDX common stock.
• The transaction was not explicitly reported as being made pursuant to a Rule 10b5-1 trading plan.

Sentiment

Score: 3

Explanation: The filing reports a director's sale of common stock, which reduces insider ownership. The absence of a Rule 10b5-1 plan indication suggests this was not a pre-scheduled, non-discretionary transaction, which can be perceived as a minor negative signal by the market.

Positives

• The transaction was transparently disclosed through an SEC Form 4, adhering to regulatory requirements.

Negatives

• Director Claire Fraser sold 863 shares of common stock, reducing her direct beneficial ownership.
• The transaction was not explicitly reported as being made pursuant to a Rule 10b5-1 trading plan, which might suggest it was not a pre-scheduled, non-discretionary sale.

Risks

• Insider sales, particularly those not explicitly disclosed as part of a pre-arranged Rule 10b5-1 plan, can sometimes be interpreted by the market as a signal of reduced confidence in the company's future performance or valuation.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• The transaction involves a director of the company, Claire Fraser, selling shares, which is a form of related party transaction.

Stakeholder Impact

• Shareholders may interpret the insider sale as a minor negative signal, though such sales are often for personal financial planning.

Key Dates

Keywords

Becton Dickinson, BDX, Form 4, Insider Trading, Share Sale, Director, Claire Fraser, Medical Devices, Healthcare